Physician profile
Collin Robert Gray
NPI 1881217446
$29,509.54
in general payments reported to CMS, 2019-2025
19 companies · $14K in 2025
The $14K reported for 2025 was more than what 99% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $185 · 2021: $1,033 · 2022: $2,874 · 2023: $5,090 · 2024: $6,252 · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,930 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $8,225 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $6,188 · Travel and Lodging: $1,812 · Consulting Fee: $200 · Gift: $62.61.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,930.30 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $8,225.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $6,187.50 |
| Travel and Lodging | $1,812.17 |
| Consulting Fee | $200.00 |
| Gift | $62.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $12,914.82 | 2020-2025 | Cequa, Xelpros, Bromsite |
| Coopervision INC. | $4,633.41 | 2021-2025 | Misight Contact Lens, Myday Contact Lens, Clariti Contact Lens |
| Lkc Technologies, INC. | $3,937.95 | 2024-2025 | |
| Lumenis Be INC | $3,800.00 | 2023 | M22 |
| Alcon Vision LLC | $989.25 | 2020-2025 | Precision7, Dailies Total1, Air Optix |
| Johnson & Johnson Vision Care, INC. | $864.55 | 2020-2025 | Acuvue |
| Bausch & Lomb Americas INC. | $794.71 | 2022-2025 | Infuse, Biotrue One Day |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $387.05 | 2020-2021 | |
| Carl Zeiss Meditec USA, INC. | $285.93 | 2025 | |
| Merz North America, INC. | $219.88 | 2022-2023 | |
| Kala Pharmaceuticals, INC. | $194.28 | 2021-2022 | |
| Tarsus Pharmaceuticals, INC. | $173.35 | 2025 | Xdemvy |
| Horizon Therapeutics Plc | $90.61 | 2023 | Tepezza |
| Valley Contax, INC. | $62.61 | 2023 | |
| Abbvie INC. | $38.64 | 2022-2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $37.14 | 2021 | |
| Johnson & Johnson Surgical Vision, INC. | $32.34 | 2023 | Lipiflow System Activator (Disposable) |
| Biotissue Holdings INC. | $30.69 | 2023-2024 | |
| Dompe US, INC. | $22.33 | 2025 | Oxervate |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Collin Gray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.